See more : Hankook Cosmetics Manufacturing Co., Ltd (003350.KS) Income Statement Analysis – Financial Results
Complete financial analysis of Elixinol Wellness Limited (ELLXF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Elixinol Wellness Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- RENK Group AG (R3NK.DE) Income Statement Analysis – Financial Results
- TruScreen Group Limited (TRU.AX) Income Statement Analysis – Financial Results
- DZS Inc. (TLFP.BE) Income Statement Analysis – Financial Results
- Federal Corporation (2102.TW) Income Statement Analysis – Financial Results
- SkyCity Entertainment Group Limited (SKYZF) Income Statement Analysis – Financial Results
Elixinol Wellness Limited (ELLXF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.elixinolwellness.com
About Elixinol Wellness Limited
Elixinol Wellness Limited, through its subsidiaries, manufactures and distributes hemp derived nutraceuticals, cosmetics, and food products under the Elixinol and Hemp Foods Australia brands in the Americas, Europe, and Australia. It offers hemp derived cannabidiol and food products, dietary supplements, topicals, and skincare products. The company was formerly known as Elixinol Global Limited and changed its name to Elixinol Wellness Limited in May 2021. The company was incorporated in 2017 and is headquartered in Sydney, Australia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 8.27M | 7.06M | 9.34M | 15.01M | 27.18M | 37.13M | 0.00 |
| Cost of Revenue | 4.85M | 3.82M | 4.44M | 8.34M | 11.56M | 17.18M | 17.00K |
| Gross Profit | 3.42M | 3.24M | 4.90M | 6.67M | 15.62M | 19.96M | -17.00K |
| Gross Profit Ratio | 41.36% | 45.90% | 52.43% | 44.41% | 57.46% | 53.74% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 6.17M | 8.08M | 12.95M | 17.54M | 19.73M | 10.76M | 6.35M |
| Selling & Marketing | 1.82M | 2.29M | 3.68M | 7.17M | 12.25M | 7.41M | 36.00K |
| SG&A | 7.99M | 10.37M | 16.64M | 24.71M | 31.98M | 18.18M | 2.72M |
| Other Expenses | -4.57M | 472.00K | 2.51M | 522.00K | 88.00K | 734.00K | 0.00 |
| Operating Expenses | 3.42M | 13.24M | 20.51M | 31.99M | 39.38M | 20.93M | 2.72M |
| Cost & Expenses | 14.26M | 17.06M | 24.95M | 40.34M | 50.95M | 38.11M | 2.74M |
| Interest Income | 213.00K | 22.00K | 47.00K | 100.00K | 559.00K | 441.00K | 6.00K |
| Interest Expense | 101.00K | 71.00K | 92.00K | 49.00K | 121.00K | 0.00 | 0.00 |
| Depreciation & Amortization | 597.00K | 721.00K | 1.49M | 3.21M | 2.80M | 612.00K | 17.00K |
| EBITDA | -6.84M | -9.28M | -14.12M | -22.11M | -22.29M | -150.00K | -8.15M |
| EBITDA Ratio | -82.71% | -117.52% | -109.00% | 348.66% | -82.00% | -0.40% | 0.00% |
| Operating Income | -5.99M | -9.01M | -11.67M | 49.12M | -24.74M | -974.00K | -2.74M |
| Operating Income Ratio | -72.44% | -127.74% | -124.95% | 327.26% | -91.02% | -2.62% | 0.00% |
| Total Other Income/Expenses | -1.51M | -1.04M | -193.00K | -78.16M | -49.85M | 477.00K | -5.46M |
| Income Before Tax | -7.50M | -10.57M | -17.09M | -100.28M | -73.62M | -497.00K | -2.73M |
| Income Before Tax Ratio | -90.75% | -149.81% | -183.02% | -668.07% | -270.82% | -1.34% | 0.00% |
| Income Tax Expense | 3.00K | 2.00K | -65.00K | 4.20M | -7.20M | 363.00K | -22.00K |
| Net Income | -7.51M | -10.57M | -17.03M | -104.51M | -83.34M | -860.00K | -2.71M |
| Net Income Ratio | -90.78% | -149.84% | -182.32% | -696.24% | -306.60% | -2.32% | 0.00% |
| EPS | -0.02 | -0.03 | -0.04 | -0.45 | -0.42 | -0.01 | -0.03 |
| EPS Diluted | -0.02 | -0.03 | -0.04 | -0.45 | -0.42 | -0.01 | -0.03 |
| Weighted Avg Shares Out | 472.14M | 406.38M | 404.77M | 230.68M | 196.99M | 125.36M | 103.09M |
| Weighted Avg Shares Out (Dil) | 473.42M | 406.38M | 404.77M | 230.68M | 196.99M | 125.36M | 102.93M |
Elixinol Global's products pass key administrative check by Food Standards Agency and can remain for sale in UK market
Elixinol to Acquire 100% of CannaCare Health
Elixinol Global positions itself as a leading pan-European CBD company by acquiring Germany's CannaCare Health
Elixinol Global in trading halt with potential transaction news pending
Elixinol Global accelerates growth strategy following global re-set of initiatives
Elixinol Global substantial holder Regal Funds Management increases stake
Source: https://incomestatements.info
Category: Stock Reports